Basso Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Basso Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-630	Closed	-$14K	–	211
2017 Q2	$14K	Buy	+630	New	+$11.4K	﹤0.01%	162

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Basso Capital Management's AMRI Position: Q3 2017 in Review

Basso Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 630 shares — an estimated $14K sold.

Basso Capital Management first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $14K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Basso Capital Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Basso Capital Management sold 630 Albany Molecular Research Inc shares in Q3 2017, an estimated $14K.
Basso Capital Management first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
Basso Capital Management's Albany Molecular Research Inc position peaked at $14K in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Basso Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.